From the April 3, 2020, edition of Fox News' Fox & Friends

DR. MEHMET OZ: Well, I think we are still getting comfortable with the data. Just to highlight the study, it’s the number 1 solution used by physicians. Now we don’t know for sure how effective it’s going to be. We have one randomized trial that’s positive, one that is negative. We have a bunch of data collected. I just got an email this morning from the French Dr. Didier Raoult, who’s almost up to 1,000 patients now. He’s going to share that with us next week on the show. So, it’s coming in quickly and generally speaking it seems to be safe, which is the first thing you want to assess. But American physicians desire large, randomized trials. I tell you, you have Dr. Fauci coming on, if you could ask a question of him for me. I’m wondering if he was impressed by or what his thoughts are on the Chinese study that we discussed yesterday from Wuhan that reflected statistically significant improvement and recovery from fever, from cough, and in the pneumonia as well, the three things that you sort of want to see in a randomized trial. Admittedly, it was small, but actually that might be an asset. If it only took 62 patients to show statistically significant benefit, which means it wasn’t just random chance, then that usually reflects a pretty powerful solution. It’s still early. We need more done, but since we’re marching into war, could we work with this army and bring them along?

…

Listen, I'm all for the need to be careful about the use of these meds cause folks who have lupus and rheumatoid arthritis don't want to run out of these meds, but fascinatingly, the Chinese say that in their experience patients taking these medications don't get COVID-19, so maybe it will actually be a prophylactic, preventive tool. We’re studying that as well at Columbia, but we have to get access to the med.